Viraferonpeg 150mcg Injection
Prescription Required
Product introduction
Viraferonpeg 150mcg Injection is used in the treatment of chronic hepatitis C virus (HCV) infection.
Viraferonpeg 150mcg Injection is used to treat serious long-term infections (chronic hepatitis B and hepatitis C) of liver.
Viraferonpeg 150mcg Injection is used to treat serious long-term infections (chronic hepatitis B and hepatitis C) of liver.
Uses of Viraferonpeg Injection
- Chronic hepatitis C virus (HCV) infection
Benefits of Viraferonpeg Injection
In Chronic hepatitis C virus (HCV) infection
Viraferonpeg 150mcg Injection helps control the infection and makes the immune system work better. This lowers your chances of getting complications and improves your quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HCV infection. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
Side effects of Viraferonpeg Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Common side effects of Viraferonpeg
- Abdominal pain
- Agitation
- Anxiety
- Blurred vision
- Cough
- Decreased appetite
- Decreased white blood cell count
- Depression
- Dizziness
- Dryness in mouth
- Fatigue
- Headache
- Impaired concentration
- Indigestion
- Insomnia (difficulty in sleeping)
- Nausea
- Nervousness
- Sore throat
- Stomatitis (Inflammation of the mouth)
- Viral infection
- Vomiting
How to use Viraferonpeg Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Viraferonpeg 150mcg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Viraferonpeg 150mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Viraferonpeg 150mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Viraferonpeg 150mcg Injection may cause side effects which could affect your ability to drive.
Patients may develop dizziness, confusion, somnolence, and fatigue while on Viraferonpeg 150mcg Injection and should be cautioned to avoid driving.
Patients may develop dizziness, confusion, somnolence, and fatigue while on Viraferonpeg 150mcg Injection and should be cautioned to avoid driving.
Kidney
UNSAFE
Viraferonpeg 150mcg Injection is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Caution should be used in patients with renal impairment.
Caution should be used in patients with renal impairment.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Viraferonpeg 150mcg Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Viraferonpeg 150mcg Injection helps treat chronic hepatitis C in adults.
- Do not drive or do anything that requires mental focus until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and 4 months after stopping the treatment.
- Your doctor may get regular blood tests done to monitor your blood cells, liver and thyroid function, and lipid levels during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat or rash.
- Inform your doctor if you notice any changes in your behavior, mood or vision.
Fact Box
Chemical Class
Interferons
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Interferons
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Peginterferon alfa-2b. Kenilworth, New Jersey: Schering Corporation; 2011. [Accessed 25 Jun. 2019] (online) Available from:
- Medscape. Peginterferon alfa 2b. [Accessed 26 Jun. 2019] (online) Available from:
- MedlinePlus. Peginterferon Alfa-2b. [Accessed 26 Jun. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Peginterferon Alfa. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
Marketer details
Name: MSD Pharmaceuticals Pvt Ltd
Address: Platina, 8th Floor, C.59, G Block, Bandra Kurla Complex, Bandra (East) , Mumbai - 400098,
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
โน12806
Inclusive of all taxes
0.5 ml in 1 vial
SOLD OUT